China's Biotech Plan

China's biotechnology industry is likely to reach a total output value of 4 trillion yuan — $630 billion — by the end of 2015, reports China Daily's Gao Yuan. The pharmaceutical sector is expected to contribute about 90 percent of that value, Yuan says, adding that, according to China Securities Journal, the country's government is considering a five-year development plan for the industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.